Exploration of Medicine

Table 3. Comparison of CBC between tremor patients and healthy controls.

Feature	Tremor/N = 51	Healthy control/N = 80	Z	P-Value	Reference range
RBC indicators
RBC (× 10¹²/L)	4.98 (4.57, 5.33)	4.89 (4.59, 5.43)	–0.224	0.823	4–5.5
Hb (g/L)	143.00 (128.00, 156.00)	144.00 (134.00, 158.00)	–0.840	0.401	130–175
HCT	0.43 (0.40, 0.47)	0.44 (0.42, 0.48)	–1.008	0.314	0.4–0.54
MCV (fL)	89.20 (86.00, 92.30)	90.20 (88.30, 92.85)	–1.407	0.159	82–94
MCH (pg)	29.60 (27.90, 30.80)	29.80 (28.70, 30.80)	–0.791	0.429	27–32
MCHC (g/L)	326.00 (321.00, 335.00)	329.00 (323.25, 332.75)	–0.269	0.788	320–360
RDW-SD (fL)	41.80 (39.60, 44.30)	41.05 (39.45, 42.70)	1.076	0.282	37–54
RDW-CV	0.13 (0.12, 0.13)	0.13 (0.13, 0.13)	–1.267	0.205	0.11–0.16
WBC indicators
WBC (× 10⁹/L)	6.13 (5.46, 7.41)	6.22 (5.47, 7.38)	–0.437	0.662	4–10
Lymphocyte (× 10⁹/L)	1.96 (1.66, 2.40)	2.10 (1.71, 2.50)	–1.076	0.282	1–3.7
Monocyte (× 10⁹/L)	0.49 (0.41, 0.62)	0.37 (0.28, 0.46)	4.938	< 0.001	0–0.7
Neutrophil (× 10⁹/L)	3.39 (2.73, 4.47)	3.65 (2.92, 4.49)	–0.961	0.337	1.5–7
Eosinophil (× 10⁹/L)	0.11 (0.07, 0.23)	0.17 (0.10, 0.24)	–2.266	0.023	0–0.4
Basophil (× 10⁹/L)	0.03 (0.02, 0.04)	0.03 (0.02, 0.04)	–0.796	0.426	0–0.1
PLT indicators
PLT (× 10⁹/L)	252.00 (212.00, 289.00)	264.00 (223.00, 287.00)	–0.810	0.418	100–300
PDW (fL)	10.15 (9.08, 11.72)	16.00 (15.80, 16.28)	–9.574	< 0.001	10–15
MPV (fL)	9.50 (8.90, 10.23)	9.40 (8.60, 9.98)	1.097	0.273	6–15
PCT	0.24 (0.20, 0.27)	0.25 (0.21, 0.27)	–0.404	0.686	0.11–0.28

Return to article view

Note: N refers to the number of participants who completed this test.

Declarations

Author contributions

YJZ: Conceptualization, Investigation, Methodology, Writing—original draft, Formal analysis, Visualization. MC: Investigation, Data curation, Writing—original draft. XHH: Investigation, Writing—original draft. SEL: Investigation, Writing—original draft. ZL: Conceptualization, Investigation, Writing—original draft, Writing—review & editing, Supervision, Funding acquisition. All authors read and approved the submitted version.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

This study was performed in line with the principles of the Declaration of Helsinki (Version 2024). Approval was granted by the Ethics Committee of Guilin Medical University (No. GYLL2022009).

Consent to participate

Written informed consent was obtained from all individual participants after explaining the goals of the study.

Consent to publication

Not applicable.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Funding

The study was supported by the National Natural Science Foundation of China (No. 32260175) and the Guangxi Key Laboratory Capacity Building Project (Guike LT2600640059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Copyright

Publisher’s note

Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.

References

Lenka A, Jankovic J. Tremor Syndromes: An Updated Review. Front Neurol. 2021;12:684835. [DOI] [PubMed] [PMC]

Louis ED, Bain PG. Problems and controversies in tremor classification. J Neurol Sci. 2022;435:120204. [DOI] [PubMed]

Welton T, Cardoso F, Carr JA, Chan LL, Deuschl G, Jankovic J, et al. Essential tremor. Nat Rev Dis Primers. 2021;7:83. [DOI] [PubMed]

Jakobs M, Lee DJ, Lozano AM. Modifying the progression of Alzheimer’s and Parkinson’s disease with deep brain stimulation. Neuropharmacology. 2020;171:107860. [DOI] [PubMed]

Tarnacka B, Jopowicz A, Maślińska M. Copper, Iron, and Manganese Toxicity in Neuropsychiatric Conditions. Int J Mol Sci. 2021;22:7820. [DOI] [PubMed] [PMC]

Kawahara M, Tanaka KI, Kato-Negishi M. Zinc, Copper, and Calcium: A Triangle in the Synapse for the Pathogenesis of Vascular-Type Senile Dementia. Biomolecules. 2024;14:773. [DOI] [PubMed] [PMC]

Tardy AL, Pouteau E, Marquez D, Yilmaz C, Scholey A. Vitamins and Minerals for Energy, Fatigue and Cognition: A Narrative Review of the Biochemical and Clinical Evidence. Nutrients. 2020;12:228. [DOI] [PubMed] [PMC]

Dolphin AC, Lee A. Presynaptic calcium channels: specialized control of synaptic neurotransmitter release. Nat Rev Neurosci. 2020;21:213–29. [DOI] [PubMed] [PMC]

Lin M, Colon-Perez LM, Sambo DO, Miller DR, Lebowitz JJ, Jimenez-Rondan F, et al. Mechanism of Manganese Dysregulation of Dopamine Neuronal Activity. J Neurosci. 2020;40:5871–91. [DOI] [PubMed] [PMC]

10.

Chin-Chan M, Montes S, Blanco-Álvarez VM, Aguirre-Alarcón HA, Hernández-Rodríguez I, Bautista E. Relevance of biometals during neuronal differentiation and myelination: in vitro and in vivo studies. Biometals. 2022;35:395–427. [DOI]

11.

Gale J, Aizenman E. The physiological and pathophysiological roles of copper in the nervous system. Eur J Neurosci. 2024;60:3505–43. [DOI]

12.

Voelker R. What Is Essential Tremor? JAMA. 2025;333:181. [DOI] [PubMed]

13.

Rajan R, Pandey S, Anandapadmanabhan R, Srivastava AK. Interrater and intrarater agreement on the 2018 consensus statement on classification of tremors. Mov Disord. 2018;33:1966–7. [DOI] [PubMed]

14.

Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022;7:378. [DOI] [PubMed] [PMC]

15.

Locatelli M, Farina C. Role of copper in central nervous system physiology and pathology. Neural Regen Res. 2025;20:1058–68. [DOI] [PubMed] [PMC]

16.

Teschke R, Eickhoff A. Wilson Disease: Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis Update. Int J Mol Sci. 2024;25:4753. [DOI] [PubMed] [PMC]

17.

Bisaglia M, Bubacco L. Copper Ions and Parkinson's Disease: Why Is Homeostasis So Relevant? Biomolecules. 2020;10:195. [DOI] [PubMed] [PMC]

18.

Desai V, Kaler SG. Role of copper in human neurological disorders. Am J Clin Nutr. 2008;88:855S–8S. [DOI] [PubMed]

19.

Eiró LG, Ferreira MKM, Frazão DR, Aragão WAB, Souza-Rodrigues RD, Fagundes NCF, et al. Lead exposure and its association with neurological damage: systematic review and meta-analysis. Environ Sci Pollut Res Int. 2021;28:37001–15. [DOI] [PubMed]

20.

Tordera RM, Cortés-Erice M. Role of Histone Deacetylases in Monocyte Function in Health and Chronic Inflammatory Diseases. Rev Physiol Biochem Pharmacol. 2021;180:1–47. [DOI] [PubMed]

21.

Jackson DJ, Akuthota P, Roufosse F. Eosinophils and eosinophilic immune dysfunction in health and disease. Eur Respir Rev. 2022;31:210150. [DOI] [PubMed] [PMC]

22.

Collins JM, Keane JM, Deady C, Khashan AS, McCarthy FP, O'Keeffe GW, et al. Prenatal stress impacts foetal neurodevelopment: Temporal windows of gestational vulnerability. Neurosci Biobehav Rev. 2024;164:105793. [DOI] [PubMed]

23.

Huang CH, Hsieh CY, Wang CW, Tu HP, Chen SC, Hung CH, et al. Associations and Interactions between Heavy Metals with White Blood Cell and Eosinophil Count. Int J Med Sci. 2022;19:331–7. [DOI] [PubMed] [PMC]

24.

Liu Y, Zhu J, Xu L, Wang B, Lin W, Luo Y. Copper regulation of immune response and potential implications for treating orthopedic disorders. Front Mol Biosci. 2022;9:1065265. [DOI] [PubMed] [PMC]

25.

Mulroy E, Baschieri F, Magrinelli F, Latorre A, Cortelli P, Bhatia KP. Movement Disorders and Liver Disease. Mov Disord Clin Pract. 2021;8:828–42. [DOI] [PubMed] [PMC]

26.

Schönfeld P, Reiser G. How the brain fights fatty acids' toxicity. Neurochem Int. 2021;148:105050. [DOI] [PubMed]

27.

Teschke R. Copper, Iron, Cadmium, and Arsenic, All Generated in the Universe: Elucidating Their Environmental Impact Risk on Human Health Including Clinical Liver Injury. Int J Mol Sci. 2024;25:6662. [DOI] [PubMed] [PMC]

28.

Ahmad S, Ärnlöv J, Larsson SC. Genetically Predicted Circulating Copper and Risk of Chronic Kidney Disease: A Mendelian Randomization Study. Nutrients. 2022;14:509. [DOI] [PubMed] [PMC]

29.

Gonzalez-Villalva A, Marcela RL, Nelly LV, Patricia BN, Guadalupe MR, Brenda CT, et al. Lead systemic toxicity: A persistent problem for health. Toxicology. 2025;515:154163. [DOI] [PubMed]

30.

Firoozichahak A, Rahimnejad S, Rahmani A, Parvizimehr A, Aghaei A, Rahimpoor R. Effect of occupational exposure to lead on serum levels of lipid profile and liver enzymes: An occupational cohort study. Toxicol Rep. 2022;9:269–75. [DOI] [PubMed] [PMC]

31.

Kalogeropoulos P, Sardeli A, Liapis G, Giannakopoulos P, Lionaki S. Nephrotic Syndrome Associated With Heavy Metals Exposure: A Case Report and Literature Review. Cureus. 2024;16:e52029. [DOI] [PubMed] [PMC]